Evidence map›Paper›PMID 23663834›Full record

ArticleBiophysical journal2013

Impaired gating of an L-Type Ca(2+) channel carrying a mutation linked to malignant hyperthermia.

Roger A Bannister, Kurt G Beam

Erratum issuedAbstract read
In one paragraph

Article in Biophysical journal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Pathogenic CaCommunications biology · 2026
    Article
  2. CaNature communications · 2024
    Article
  3. CaInternational journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. A skeletal muscle L-type CaThe Journal of biological chemistry · 2018
    Article
  9. Article
  10. Article
  11. Channelopathies of skeletal muscle excitability.Comprehensive Physiology · 2015
    Review
  12. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

2 authors.

Roger A BannisterDepartment of Medicine, Cardiology Division, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado, USA. roger.bannister@ucdenver.edu
Kurt G Beam

Funding

Uncovering the Molecular Basis of Malignant HyperthermiaP01AR052354 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FRANZINI-ARMSTRONG, CLARA · 2006 to 2016
$13.4M
REGULATION OF MEMBRANE EXCITABILITYR01NS024444 · NINDS · UNIVERSITY OF COLORADO DENVER · PI BEAM, KURT G · 1986 to 2005
$1.8M
RGK proteins and aging muscleR03AG038778 · NIA · UNIVERSITY OF COLORADO DENVER · PI BANNISTER, ROGER ALAN · 2011 to 2012
$122k
NIAMS NIH HHS 2P01 AR052354NIAMS NIH HHS P01 AR052354NIA NIH HHS AG038778NIA NIH HHS R03 AG038778NINDS NIH HHS NS24444NINDS NIH HHS R01 NS024444
6 · The paper itself

Abstract

Recently, we characterized the functional properties of a mutant skeletal muscle L-type Ca(2+) channel (CaV1.1 R174W) linked to the pharmacogenetic disorder malignant hyperthermia. Although the R174W mutation neutralizes the innermost basic amino acid in the voltage-sensing S4 helix of the first conserved membrane repeat of CaV1.1, the ability of the mutant channel to engage excitation-contraction coupling was largely unaffected by the introduction of the bulky tryptophan residue. In stark contrast, the mutation ablated the ability of CaV1.1 to produce L-type current under our standard recording conditions. In this study, we have investigated the mechanism of channel dysfunction more extensively. We found that CaV1.1 R174W will open and conduct Ca(2+) in response to strong or prolonged depolarizations in the presence of the 1,4-dihydropyridine receptor agonist ±Bay K 8644. From these results, we have concluded that the R174W mutation impedes entry into both mode 1(low Po) and mode 2 (high Po) gating states and that these gating impairments can be partially overcome by maneuvers that promote entry into mode 2.

Indexed as

Mutation, Missense3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterAction PotentialsAnimalsCalciumCalcium Channel AgonistsCalcium Channels, L-TypeIon Channel GatingMalignant HyperthermiaMembrane PotentialsMiceMuscle Fibers, Skeletal3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl esterCACNA1S protein, mouseCalciumCalcium Channel AgonistsCalcium Channels, L-Type

Identifiers

PMID23663834
PMCPMC3647151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.